Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma.
Medicine (Baltimore)
; 98(25): e16074, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-31232945
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Drug Therapy, Combination
/
Sorafenib
/
Liver Neoplasms
Type of study:
Prognostic_studies
Country/Region as subject:
Asia
Language:
En
Journal:
Medicine (Baltimore)
Year:
2019
Type:
Article